|
Short Course Development & Quality Assurance
Task Force Co-Chairs
Kati Copley-Merriman MS, MBA,
Director of Outcomes Research, Pfizer Pharmaceuticals, Ann Arbor, MI, USA and
Lorne E. Basskin PharmD, Assistant Professor,
Butler University, Indianapolis, IN, USA
Committee Members
Karen F. Gold PhD,
Director, Biostatistics and Outcomes Research, Abt Associates, Bethesda, MD, USA
David Lilienfeld MD, MS, MPH, Associate Director,
Pharmacoepidemiology, Bristol Myers-Squibb Company, Princeton, NJ, USA
Michael Minshall MPH, Health Outcomes Research
Scientist, Eli Lilly and Company, Indianapolis, IN, USA
Amy Phillips PharmD, Outcomes Research Fellow,
Abbott Laboratories, Abbott Park, IL, USA
ISPOR Short Course Educational Objectives
| ISPOR Short Courses are provided to
enhance the development of individuals involved in pharmacoeconomics and
outcomes research or who use this research in health care decision-making.
Faculties, who have published in the specific discipline, present these
courses. Each participant receives a course workbook and an ISPOR
Certificate of Completion. The participant will learn new methodologies
and outcomes research techniques, improve skills in the specific course
subject selected, and be able to apply learned skills to his/her specific
work environment. |
|
Pharmacoeconomics for the
Healthcare Decision Maker
Lorne E. Basskin PharmD, Associate Professor, College of Pharmacy and
Health Sciences, Butler University, IN, USA
Course Description: This one-day short course is designed to teach
clinicians and new researchers how to incorporate pharmacoeconomics into study
design and data analysis. Participants will learn how to collect and calculate
the costs of different alternatives, determine the economic impact of clinical
outcomes, and how to identify, track and assign costs to different types of
health care resources used. The development of economic protocols and data
collection sheets will be discussed. Different pharmacoeconomic models and
techniques will be demonstrated and practiced in lectures and case studies.
These include cost-minimization, cost-of-illness, cost-effectiveness,
cost-benefit, and cost-utility analysis. Decision analysis, sensitivity
analysis, and discounting, will all be demonstrated and practiced.
Participants will also learn to compare and evaluate interventions such as
drugs, devices and clinical services. |
